Grant: Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
University of Ottawa
$5,000.00
Exploring the role of Wnt signalling in the directed differentiation of embryonic stem cells into skeletal muscle
FY 2013-14
Summary
Currently, there are no effective treatments for patients with neuromuscular diseases, such as muscular dystrophy. Gene therapy approaches, while still promising, have had several setbacks. A method to repair and reverse muscle wasting would greatly enhance the outcome for these patients. Developing novel therapeutic methods will require enhancing our basic understanding of how skeletal muscle is made and repairs itself. Our current proposal addresses the way that muscle is formed in mouse embryonic stem (ES) cells. These cells can proliferate indefinitely to create near-unlimited numbers of stem cells, and are capable of differentiating into almost any other cell type. The major difficulty with using ES cells for cell therapy is that only a small population of ES cells can differentiate into skeletal muscle. Understanding how ES cells differentiate into skeletal muscle may reveal novel techniques for increasing this population of stem cells, and will aid in the development of innovative therapies.
We have shown that signaling through the Wnt pathway can increase the production of the Pax3 and Pax7 proteins in stem cells. This is important because Pax3 and Pax7 proteins are characteristic of muscle progenitor cells that can proliferate and differentiate efficiently into skeletal muscle. A chemical activator of Wnt signaling, known as CHIR99021, can induce the formation of these progenitor cells. How Wnt signaling is able to regulate formation of skeletal muscle is not clear. We hypothesize that through biochemical methods, the regulation of Wnt signaling throughout skeletal muscle formation may be revealed. We will determine the changes at the molecular level occurring throughout a growth cycle of mouse ES cells treated with CHIR. With this information, it may be possible to manipulate stem cells to form higher populations of transplantable, therapeutic material.
Department
Program
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
303407
Name
Metz Jeff
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Undergraduate: Mobility, musculoskeletal health & arthritis - IMHA
Projecttitle
Exploring the role of Wnt signalling in the directed differentiation of embryonic stem cells into skeletal muscle
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$5,000
Cihrequipment2
$0
Programname2
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Keyworddelim
Biochemistry; Facs; Immunofluorescence; Myogenesis; Qpcr; Rna-Seq; Stem Cells; Tissue Culture; Western Blot; Wnt Signaling
Abstract
Currently, there are no effective treatments for patients with neuromuscular diseases, such as muscular dystrophy. Gene therapy approaches, while still promising, have had several setbacks. A method to repair and reverse muscle wasting would greatly enhance the outcome for these patients. Developing novel therapeutic methods will require enhancing our basic understanding of how skeletal muscle is made and repairs itself. Our current proposal addresses the way that muscle is formed in mouse embryonic stem (ES) cells. These cells can proliferate indefinitely to create near-unlimited numbers of stem cells, and are capable of differentiating into almost any other cell type. The major difficulty with using ES cells for cell therapy is that only a small population of ES cells can differentiate into skeletal muscle. Understanding how ES cells differentiate into skeletal muscle may reveal novel techniques for increasing this population of stem cells, and will aid in the development of innovative therapies.
We have shown that signaling through the Wnt pathway can increase the production of the Pax3 and Pax7 proteins in stem cells. This is important because Pax3 and Pax7 proteins are characteristic of muscle progenitor cells that can proliferate and differentiate efficiently into skeletal muscle. A chemical activator of Wnt signaling, known as CHIR99021, can induce the formation of these progenitor cells. How Wnt signaling is able to regulate formation of skeletal muscle is not clear. We hypothesize that through biochemical methods, the regulation of Wnt signaling throughout skeletal muscle formation may be revealed. We will determine the changes at the molecular level occurring throughout a growth cycle of mouse ES cells treated with CHIR. With this information, it may be possible to manipulate stem cells to form higher populations of transplantable, therapeutic material.
Competitiondate
201401
Approvedterm2
0 yr 3 mths
Pinamesdelim
Metz, Jeff
Approvedterm
0 an 3 mois
Cihrcontribution2
~ $5,000~ $0~